{"id":"W3206372141","doi":"10.1016/j.ejca.2021.09.016","title":"Contemporary dose-escalation methods for early phase studies in the immunotherapeutics era","year":2021,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Bristol-Myers Squibb Canada; Astellas Pharma Canada; International Studies Association; Novartis; Celgene; Bayer; AstraZeneca; Amgen; Pfizer; Meso Scale Diagnostics; AbbVie; Merck","keywords":"Maximum tolerated dose; Medicine; Clinical trial; Therapeutic window; Intensive care medicine; Medical physics; Computer science; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004049418,0.001066856,0.003055342,0.001511244,0.0002587736,0.002104418,0.002308901,0.001479577,0.007457671],"category_scores_gemma":[0.00437435,0.0003988897,0.001577731,0.001661923,0.0008972278,0.001834682,0.0008259612,0.00456611,0.001872581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00146733,"about_ca_system_score_gemma":0.001755828,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001119521,"about_ca_topic_score_gemma":0.002032159,"domain_scores_codex":[0.9991363,0.000332824,0.00008763475,0.0001564562,0.0002241944,0.00006260668],"domain_scores_gemma":[0.9971067,0.002131132,0.00027386,0.00009914069,0.0003025716,0.00008646603],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004317662,0.0001539134,0.0001594187,0.01257084,0.0002155111,0.00005176116,0.00004894155,0.001271173,0.001425642,0.004820389,0.01134683,0.9675037],"study_design_scores_gemma":[0.0009335815,0.001231502,0.002292122,0.01268741,0.0009549109,0.001613512,0.0001000808,0.001170412,0.001946776,0.0111839,0.9658093,0.00007651116],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003676187,0.9959192,0.001436539,0.0007897554,0.0001866887,0.00005724675,0.00006671913,0.00002935946,0.001147037],"genre_scores_gemma":[0.005276639,0.9872183,0.004145936,0.00146678,0.0003774476,0.0001868941,0.0002039918,0.000030163,0.001093855],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9959506,"threshold_uncertainty_score":0.02494842,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4579977353478128,"score_gpt":0.597604700362081,"score_spread":0.1396069650142682,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}